Thermo Fisher Scientific (TMO) Operating Expenses (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Operating Expenses for 18 consecutive years, with $9.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 9.82% year-over-year to $9.9 billion; the trailing twelve-month figure through Jun 2026 stood at $38.2 billion (up 6.66% YoY), and the FY2025 full-year result was $36.8 billion, up 3.57% from the prior year.
• Operating Expenses rose to $9.9 billion in Q2 2026 per TMO's latest filing, from $9.1 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $10.0 billion in Q4 2025 and bottomed at $8.6 billion in Q1 2025.
• Historically, Operating Expenses has averaged $9.1 billion across 5 years, with a median of $9.0 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 31.21% in 2022, then declined 5.81% in 2023.
• Over 5 years, Operating Expenses stood at $9.6 billion in 2022, then dropped by 5.81% to $9.0 billion in 2023, then rose by 3.84% to $9.4 billion in 2024, then gained by 6.19% to $10.0 billion in 2025, then fell by 0.53% to $9.9 billion in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $9.9 billion, $9.1 billion, and $10.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.